Chile’s National Economic Prosecutor (FNE) has said it received a new complaint regarding possible instances of collusion between major drug-store chains, this time affecting the Valdivia region. The complaint, presented by the Movimiento Autónomo Regional de Los Rios (Los Rios Autonomous Regional Movement), has sought to bring attention to this problem, which they claim affects several communal areas.
Miguel Ángel Carrasco, a physician and member of the Los Ríos movement, explained that their suspicions were raised due to the minimal difference in prices found among the most common medications used by Chilean consumers. The group has gathered and presented the FNE with data collected from communal villages in the Valdivia and Union regions, with price comparisons for various brands of medication, including anti-inflammatory and anti-anxiety medication.
Full Content: Bio Bio Chile
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Justice Department Moves to End NCAA Transfer Rule
May 30, 2024 by
CPI
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI